Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04079010 · ClinicalTrials.gov registry record · NA
The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone
A NA study of Blood Flow Restriction and Growth Hormone, sponsored by University of Mary Hardin-Baylor.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04079010 is a NA study of Blood Flow Restriction and Growth Hormone that has completed, run by University of Mary Hardin-Baylor. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04079010, a NA study of Blood Flow Restriction and Growth Hormone, has completed, sponsored by University of Mary Hardin-Baylor.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The current study will investigate the effects of Blood Flow Restriction (BFR) training and L-arginine supplementation on recreationally trained female participants. In particular, it will compare performance outcomes and blood markers among two intervention groups (BFR and BFR+Arg) and a control group (CON).
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Arginine
- PROCEDURE BFR
- DIETARY_SUPPLEMENT Placebo Pill
Study Locations (1)
Texas
- University of Mary Hardin-Baylor - Belton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-09-04 |
| Est. Completion | 2019-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04079010
The ClinicalTrials.gov registry entry for NCT04079010 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mary Hardin-Baylor, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Blood Flow Restriction appearing as the primary indexed condition, and to 3 interventions - of which Arginine is the first listed.
NCT04079010 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04079010 about?
NCT04079010 is a clinical study titled "The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone". The current study will investigate the effects of Blood Flow Restriction (BFR) training and L-arginine supplementation on recreationally trained female participants. In particular, it will compare performance outcomes and blood markers among two intervention groups (BFR and BFR+Arg) and a control gr...
What is the current status of trial NCT04079010?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-09-04. Estimated completion is 2019-11-25.
What conditions does trial NCT04079010 study?
This clinical trial studies the following conditions: Blood Flow Restriction, Growth Hormone, Strength Outcomes, Arginine.
What interventions are being tested in trial NCT04079010?
The interventions under investigation include: Arginine (DIETARY_SUPPLEMENT), BFR (PROCEDURE), Placebo Pill (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04079010?
This trial is sponsored by University of Mary Hardin-Baylor, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04079010 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Flow Restriction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.